Geriatric Medicine

For decades, scientists have known that people with type 2 diabetes face a higher risk of heart disease, kidney disease, cognitive decline, and other age-related conditions. However, emerging research suggests these complications may be linked to something even more fundamental: accelerated biological aging in diabetes. In other words, diabetes may …

The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment. Medications such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) are helping patients achieve levels of weight loss that were previously difficult to attain without bariatric surgery. However, as clinicians celebrate these advances, a …

Type 2 diabetes management has evolved rapidly over the past decade. As new therapies improve glucose control and cardiometabolic outcomes, many patients achieve better metabolic stability than before. However, this progress often comes with a challenge: medication overload. Deprescribing in diabetes care has emerged as a thoughtful clinical approach that …

Managing diabetes in older adults isn’t just about adjusting medications—it’s about seeing the full picture of aging, frailty, and functionality. New 2025 standards highlight the need to assess frailty and functional status when setting A1C goals in elderly patients. But how do clinicians know when it’s time to de-intensify therapy …

As more patients with diabetes achieve and maintain glycemic targets, the conversation is shifting from “how can we intensify therapy?” to “when is it safe and appropriate to de‑intensify diabetes therapy?” De‑intensify diabetes therapy is becoming a high‑value clinical goal for many clinicians caring for adults with type 2 diabetes, …

In clinical practice, caring for a diabetes in aging population goes far beyond optimizing hemoglobin A1C. While glycemic control remains central, older adults with diabetes often face unique challenges such as sarcopenia, increased risk of falls, and progressive loss of functional independence. How can clinicians proactively identify these risks and …

Early in training, many clinicians learn the classic “eye–kidney–foot” framework for recognizing and managing complications of diabetes. However, as science advances, the range of recognized consequences of diabetes—and opportunities for earlier intervention—continues to broaden. Today, the concept of diabetes complications screening must evolve to include conditions such as metabolic dysfunction–associated …

Diabetes is a chronic condition that can have a significant impact on the quality of life of elderly patients. Managing diabetes in the elderly can be challenging due to the unique needs and challenges associated with this population. This article provides an overview of diabetes in elderly patients, identifies challenges …

Type 2 diabetes is a growing health concern among older adults, with an estimated 29 million individuals over the age of 65 in the United States alone being diagnosed with the condition. While type 2 diabetes can affect people of all ages, it is particularly prevalent among older adults due …

There is strong evidence that circulating markers of systemic inflammation can predict long-term cognitive decline among older people with type 2 diabetes.